Eversept Partners, LP Astrazeneca PLC Call Options Transaction History

Eversept Partners, LP

  • $1.26 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Nov 08, 2023
SELL
$59.26 - $71.14 $16.1 Million - $19.4 Million
-272,000 Reduced 47.53%
300,300 $19.8 Million
Q1 2022

Nov 08, 2023
BUY
$55.72 - $67.12 $31.9 Million - $38.4 Million
572,300 New
572,300 $38 Million
Q4 2021

Nov 08, 2023
BUY
$54.02 - $63.83 $16.9 Million - $19.9 Million
312,000 Added 119.86%
572,300 $33.3 Million
Q3 2021

Nov 08, 2023
BUY
$55.56 - $60.79 $14.5 Million - $15.8 Million
260,300 New
260,300 $15.6 Million

Others Institutions Holding AZN

# of Institutions
1,361
Shares Held
475M
Call Options Held
5.39M
Put Options Held
3.75M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email